Blog
Melanotan II: what an early human experiment actually tested
The paper’s question is narrower than many product discussions. Evidence for one physiological response cannot validate unrelated uses or an acceptable overall risk profile.
Evidence discussed: Small controlled human trial.
What the researchers studied
A double-blind crossover study enrolled ten men with erectile dysfunction without a known organic cause. Researchers compared Melanotan-II with placebo and recorded erection-related measurements. Several short-term outcomes favored the active intervention. [1]
How to interpret the result
Nausea, yawning, stretching and reduced appetite were more frequent after exposure. The small study did not establish long-term safety, cosmetic tanning effects or skin-cancer outcomes.
What readers can take from it
The paper’s question is narrower than many product discussions. Evidence for one physiological response cannot validate unrelated uses or an acceptable overall risk profile.
This original editorial summary provides no diagnosis, dosing or treatment advice. The study did not test or certify a PeptiKing product.
Source
[1] Melanotan-II in psychogenic erectile dysfunction (1998). PMID: 9679884. Based on the PubMed-indexed abstract and record; full-text methods were not independently reviewed.